|
|
| | Bermekimab Basic information |
| Product Name: | Bermekimab | | Synonyms: | Bermekimab;Research Grade Bermekimab;Bermekimab (anti-IL-1a);MABp1 | | CAS: | 1401965-15-8 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Bermekimab Structure]() |
| | Bermekimab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Bermekimab Usage And Synthesis |
| Uses | Bermekimab (MABp1) is a human monoclonal antibody that targets interleukin-1alpa (IL-1α). Bermekimab prevents tumour-related inflammation[1]. | | References | [1] McDonald JJ, et, al. Targeting IL-1α in cancer cachexia: a narrative review. Curr Opin Support Palliat Care. 2018 Dec;12(4):453-459. DOI:10.1097/SPC.0000000000000398 |
| | Bermekimab Preparation Products And Raw materials |
|